125 related articles for article (PubMed ID: 38416410)
21. UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line.
Warner KA; Oklejas AE; Pearson AT; Zhang Z; Wu W; Divi V; Rodriguez-Ramirez C; Castilho RM; Polverini PJ; Nör JE
Oral Oncol; 2018 Dec; 87():21-28. PubMed ID: 30527239
[TBL] [Abstract][Full Text] [Related]
22. Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.
Andersson MK; Afshari MK; Andrén Y; Wick MJ; Stenman G
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954282
[TBL] [Abstract][Full Text] [Related]
23. Integrated, genome-wide screening for hypomethylated oncogenes in salivary gland adenoid cystic carcinoma.
Shao C; Sun W; Tan M; Glazer CA; Bhan S; Zhong X; Fakhry C; Sharma R; Westra WH; Hoque MO; Moskaluk CA; Sidransky D; Califano JA; Ha PK
Clin Cancer Res; 2011 Jul; 17(13):4320-30. PubMed ID: 21551254
[TBL] [Abstract][Full Text] [Related]
24. Newly Identified Members of FGFR1 Splice Variants Engage in Cross-talk with AXL/AKT Axis in Salivary Adenoid Cystic Carcinoma.
Humtsoe JO; Kim HS; Leonard B; Ling S; Keam B; Marchionni L; Afsari B; Considine M; Favorov AV; Fertig EJ; Kang H; Ha PK
Cancer Res; 2021 Feb; 81(4):1001-1013. PubMed ID: 33408119
[TBL] [Abstract][Full Text] [Related]
25. Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands.
Agulnik M; Cohen EW; Cohen RB; Chen EX; Vokes EE; Hotte SJ; Winquist E; Laurie S; Hayes DN; Dancey JE; Brown S; Pond GR; Lorimer I; Daneshmand M; Ho J; Tsao MS; Siu LL
J Clin Oncol; 2007 Sep; 25(25):3978-84. PubMed ID: 17761983
[TBL] [Abstract][Full Text] [Related]
26. RASSF1A promoter hypermethylation is a strong biomarker of poor survival in patients with salivary adenoid cystic carcinoma in a Chinese population.
Zhang CY; Zhao YX; Xia RH; Han J; Wang BS; Tian Z; Wang LZ; Hu YH; Li J
PLoS One; 2014; 9(10):e110159. PubMed ID: 25302792
[TBL] [Abstract][Full Text] [Related]
27. Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib.
Vidal L; Tsao MS; Pond GR; Cohen EE; Cohen RB; Chen EX; Agulnik M; Hotte S; Winquist E; Laurie S; Hayes DN; Ho J; Dancey J; Siu LL
Head Neck; 2009 Aug; 31(8):1006-12. PubMed ID: 19309723
[TBL] [Abstract][Full Text] [Related]
28. The value of MYB as a prognostic marker for adenoid cystic carcinoma: Meta-analysis.
Liu X; Chen D; Lao X; Liang Y
Head Neck; 2019 May; 41(5):1517-1524. PubMed ID: 30759319
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic implications of Myb and Beta-catenin expression in adenoid cystic carcinoma.
Park S; Vora M; van Zante A; Humtsoe J; Kim HS; Yom S; Agarwal S; Ha P
J Otolaryngol Head Neck Surg; 2020 Jul; 49(1):48. PubMed ID: 32650834
[TBL] [Abstract][Full Text] [Related]
30. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation.
West RB; Kong C; Clarke N; Gilks T; Lipsick JS; Cao H; Kwok S; Montgomery KD; Varma S; Le QT
Am J Surg Pathol; 2011 Jan; 35(1):92-9. PubMed ID: 21164292
[TBL] [Abstract][Full Text] [Related]
31. Study of MYB-NFIB chimeric gene expression, tumor angiogenesis, and proliferation in adenoid cystic carcinoma of salivary gland.
Ono J; Okada Y
Odontology; 2018 Jul; 106(3):238-244. PubMed ID: 29243184
[TBL] [Abstract][Full Text] [Related]
32. MYB RNA detection by in situ hybridisation has high sensitivity and specificity for the diagnosis of adenoid cystic carcinoma.
Tadi S; Cheung VK; Lee CS; Nguyen K; Luk PP; Low TH; Palme C; Clark J; Gupta R
Pathology; 2023 Jun; 55(4):456-465. PubMed ID: 37055331
[TBL] [Abstract][Full Text] [Related]
33. Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors.
Sousa LG; McGrail DJ; Lazar Neto F; Li K; Marques-Piubelli ML; Ferri-Borgogno S; Dai H; Mitani Y; Spardy Burr N; Cooper ZA; Kinneer K; Cortez MA; Lin SY; Bell D; El Naggar A; Burks J; Ferrarotto R
Clin Cancer Res; 2023 Aug; 29(16):3162-3171. PubMed ID: 37256648
[TBL] [Abstract][Full Text] [Related]
34. Early stage minor salivary gland adenoid cystic carcinoma has favourable prognosis.
Hämetoja H; Hirvonen K; Hagström J; Leivo I; Saarilahti K; Apajalahti S; Haglund C; Mäkitie A; Bäck L
Virchows Arch; 2017 Dec; 471(6):785-792. PubMed ID: 28600602
[TBL] [Abstract][Full Text] [Related]
35. A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC.
Chau NG; Hotte SJ; Chen EX; Chin SF; Turner S; Wang L; Siu LL
Ann Oncol; 2012 Jun; 23(6):1562-70. PubMed ID: 22080184
[TBL] [Abstract][Full Text] [Related]
36. Identification of methylated genes in salivary gland adenoid cystic carcinoma xenografts using global demethylation and methylation microarray screening.
Ling S; Rettig EM; Tan M; Chang X; Wang Z; Brait M; Bishop JA; Fertig EJ; Considine M; Wick MJ; Ha PK
Int J Oncol; 2016 Jul; 49(1):225-34. PubMed ID: 27212063
[TBL] [Abstract][Full Text] [Related]
37. Spatio-Temporal Genomic Heterogeneity, Phylogeny, and Metastatic Evolution in Salivary Adenoid Cystic Carcinoma.
Liu B; Mitani Y; Rao X; Zafereo M; Zhang J; Zhang J; Futreal PA; Lozano G; El-Naggar AK
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117356
[TBL] [Abstract][Full Text] [Related]
38. Zebrafish blastomere screen identifies retinoic acid suppression of
Mandelbaum J; Shestopalov IA; Henderson RE; Chau NG; Knoechel B; Wick MJ; Zon LI
J Exp Med; 2018 Oct; 215(10):2673-2685. PubMed ID: 30209067
[TBL] [Abstract][Full Text] [Related]
39. A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact.
Locati LD; Perrone F; Cortelazzi B; Bergamini C; Bossi P; Civelli E; Morosi C; Lo Vullo S; Imbimbo M; Quattrone P; Dagrada GP; Granata R; Resteghini C; Mirabile A; Alfieri S; Orlandi E; Mariani L; Saibene G; Pilotti S; Licitra L
Eur J Cancer; 2016 Dec; 69():158-165. PubMed ID: 27821319
[TBL] [Abstract][Full Text] [Related]
40. Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study.
Hotte SJ; Winquist EW; Lamont E; MacKenzie M; Vokes E; Chen EX; Brown S; Pond GR; Murgo A; Siu LL
J Clin Oncol; 2005 Jan; 23(3):585-90. PubMed ID: 15659505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
